Fig. 1From: Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics dataDrug repurposing approach to identify novel anti-melanoma drugs; in this approach we have collected melanoma responsive genes/proteins and identified target genes by drug target mapping with the help of drugbank. We have removed all known anti-melanoma drugs and analyzed the unknown anti-melanoma drugs by pathogenesis information and CMap analysis. We have found 35 drugs interacting with 20 targetsBack to article page